Omeros

OMER

OMER Omeros NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    OMER Chart
    See on advanced chart >

    About

    Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The company's most clinically advanced...
    • Highlight
      A biopharmaceutical company that developing small-molecule and protein therapeutics for orphan indications targeting immunologic diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      10/08/2009
    • Established Date
      Invalid Date
    • Full-time Employees
      198
    • Address
      201 Elliott Avenue West Seattle Washington 98119
    • Tel
      1-206-6765000
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock